Skip to main content
. 2020 Sep 30;371:m3513. doi: 10.1136/bmj.m3513

Table 2.

Characteristics of patients who received and did not receive cardiopulmonary resuscitation. Data are numbers (percentages) unless stated otherwise

Characteristic Received CPR (n=400, 57.1%) Did not receive CPR (n=301, 42.9%) P value
ICU beds
<50 237/400 (59.3) 197/301 (65.4) 0.10
50-99 82/400 (20.5) 62/301 (20.6) 0.99
≥100 81/400 (20.3) 42/301 (14.0) 0.04
Demographics
Age (years; mean (SD)) 61 (14) 67 (14) <0.001
 <45 52/400 (13.0) 16/301 (5.3) 0.001
 45-64 172/400 (43.0) 105/301 (34.9) 0.04
 65-79 142/400 (39.5) 128/301 (42.5) 0.06
 ≥80 34/400 (8.5) 52/301 (17.3) 0.001
Male sex 266/400 (66.5) 192/301 (63.8) 0.46
Race
 White (non-Hispanic) 84/400 (21.0) 66/301 (21.9) 0.78
 Black (non-Hispanic) 131/400 (32.8) 95/301 (31.6) 0.75
 Hispanic 38/400 (9.5) 29/301 (9.6) 0.99
 Asian 26/400 (6.5) 17/301 (5.6) 0.75
 Unknown 121/400 (30.3) 94/301 (31.2) 0.80
Body mass index (mean (SD))* 32 (8) 32 (10) 0.92
 <30 150/366 (41.0) 133/290 (45.9) 0.23
 30-34 114/366 (31.1) 75/290 (25.9) 0.14
 35-39 47/366 (12.8) 29/290 (10.0) 0.27
 ≥40 55/366 (15.0) 53/290 (18.3) 0.29
Coexisting conditions and risk factors†
Current or former tobacco use* 171/327 (52.3) 142/237 (59.9) 0.46
Diabetes mellitus 201/400 (50.2) 139/301 (46.2) 0.29
Hypertension 253/400 (63.2) 222/301 (73.8) 0.003
Coronary artery disease 67/400 (16.8) 46/301 (15.3) 0.60
Congestive heart failure 47/400 (11.8) 31/301 (10.3) 0.55
Chronic obstructive pulmonary disease 31/400 (7.8) 25/301 (8.3) 0.79
Chronic or end stage kidney disease 84/400 (21.0) 64/301 (21.3) 0.93
Active malignancy 17/400 (4.3) 22/301 (7.3) 0.08
Laboratory values on day of ICU admission (median (IQR))
White cell count (per mm3) 10.1 (7.0-14.3) 10.1 (7.1-14.4) 0.70
Lymphocyte count (per mm3) 9.0 (5.0-14.0) 7.3 (4.6-12.7) 0.05
Hemoglobin (g/dL) 12.5 (10.6-13.8) 12.3 (10.6-13.7) 0.57
Platelet count (103/μL) 217 (168-284) 226 (159-291) 0.99
Creatinine (mg/dL) 1.30 (0.90-2.40) 1.51 (0.96-2.49) 0.08
Albumin (g/dL) 3.1 (2.7-3.5) 3.1 (2.7-3.5) 0.94
Aspartate aminotransferase (U/L) 65 (41-120) 62 (36-99) 0.15
Alanine aminotransferase (U/L) 42 (25-76) 39 (23-59) 0.04
Total bilirubin (mg/dL) 0.6 (0.4-0.9) 0.6 (0.4-0.9) 0.75
Lactate (mmol/L) 2.2 (1.3-3.4) 2 (1.4-2.9) 0.22
Arterial pH 7.32 (7.22-7.44) 7.35 (7.25-7.42) 0.07
D dimer (ng/mL) 2637 (1283-8680) 2180 (1160-7955) 0.44
C reactive protein (mg/L) 157 (83-249) 190.9 (110-269) 0.04
Ferritin (ng/mL) 1225 (636-2591) 1255 (599.43-2784) 0.84
mSOFA score on ICU admission
Mean (SD) 5.9 (3.3) 6.2 (3.3) 0.26
Complications‡
Invasive mechanical ventilation 257/400 (64.3) 234/301 (77.7) <0.001
On extracorporeal membrane oxygenation 13/400 (3.3) 1/301 (0.3) <0.001
Newly diagnosed reduced left ventricular function§ 29/400 (7.2) 19/301 (6.3) 0.70
Receipt of at least two vasopressors 226/400 (56.5) 197/301 (65.4) 0.001
Acute kidney injury requiring RRT 78/400 (19.5) 83/301 (27.6) 0.01

ICU=intensive care unit; IQR=interquartile range; mSOFA=modified sequential organ Failure assessment score; RRT=renal replacement therapy; SD=standard deviation.

*

Denominator differs in variables for smoking and body mass index because of missing data for these specific variables (listed in supplementary appendix).

Definitions of coexisting conditions are provided in supplementary appendix.

Before cardiac arrest.

§

Defined as newly diagnosed left ventricular ejection fraction less than 50% on echocardiogram.